India - An Emerging Pharmaceutical Export Hub, Says RNCOS

Released on: August 25, 2008, 3:21 am

Press Release Author: Shushmul Maheshwari

Industry: Healthcare

Press Release Summary: India is proving its worth in the pharma market as drug
exports from the country are expected to grow 18.5%, thanks to low cost benefits and
reverse engineering skills it provide.

Press Release Body: India has emerged as one of the world’s most potential
destinations for pharmaceutical exports, with the country exporting drugs worth US$
7.2 Billion in 2007-08, according to a new research report, “Booming Pharma
Sector in India”, by RNCOS.

The research says that the Indian pharmaceutical companies hold a very strong
competitive advantage in drug manufacturing over their western counterparts in terms
of cost of production and reverse engineering skills. The cost of manufacturing both
bulk drugs as well as formulations in India is around 10%-20% of the cost it takes
in the west. Moreover, many Indian manufacturers have upgraded their manufacturing
plants, enabling India to have one of the highest numbers of plants certified by the
FDA, EDQM and various other regulatory agencies. This has made Indian companies to
venture into highly regulated but lucrative markets of northern America and Europe.

The US and Europe remains the biggest export destinations for Indian generic
manufacturers. However, Indian companies are also increasing their presence in
emerging markets such as those in Central and Eastern Europe, Latin America and
Africa, owing to lower competition and low entry barriers.

The report forecasts that pharmaceutical exports from India will grow at a CAGR of
18.5% between 2007-08 and 2011-12. This growth will be in particular driven by
multibillion dollar patent expirations and growth in the global generics market. In
addition, stringent price control norms in the Indian market are turning
manufactures to exports in order to reap better margins.

“Booming Pharma Sector in India” contains unique market-based research
and provides detailed and objective analysis on the Indian pharmaceutical market. It
presents a thorough statistical and analytical overview on the Indian pharmaceutical
market, and provides past, present and future data on the structure, composition and
working of the Indian pharmaceutical market. The research extensively discusses the
opportunities and challenges that are expected to arise within and from the
pharmaceutical market.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM131.htm
Current Industry News: http://www.rncos.com/Blog/

Web Site: http://www.rncos.com

Contact Details: 29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
91-11-4214-1228
info@rncos.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •